MEDICAL SECOND OPINION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Medical Second Opinion Market Size and Trends

The medical second opinion market is estimated to be valued at USD 7.12 Bn in 2024 and is expected to reach USD 20.45 Bn by 2031, growing at a compound annual growth rate (CAGR) of 16.3% from 2024 to 2031.

Discover market dynamics shaping the industry: Request sample copy

The market is driven by the increasing awareness about the benefits of second opinions and the rising occurrence of chronic and complex diseases. The trend of patients seeking multiple consultations prior to finalizing the treatment plan is growing significantly. Moreover, the increasing adoption of digital health platforms for virtual second opinions and the surge in partnerships between leading players are some key trends in the medical second opinion market.

Rising demand for accurate diagnosis and custom treatment plans

With the advancement of technology, allowing for more precise diagnostic tools and treatment options, patients are increasingly seeking multiple medical opinions to ensure an accurate diagnosis and tailored treatment plan. Factors, such as the rising complexity of diseases, availability of newer drugs and therapies, and the critical nature of many medical decisions, are driving patients to look beyond a single doctor's consultation. They want to weigh different perspectives and confidently choose the best path forward - whether that be a second scan to rule out abnormalities, input from another specialist, or considering an alternate treatment approach. The medical landscape is also becoming more specialized, making cross-consults more prudent. Getting additional expert advice helps address uncertainty and gives patients peace of mind in their healthcare decisions. This trend is especially prominent for serious illnesses where getting the right diagnosis and care plan first time is paramount for overall outcomes.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Request sample copy

Alongside seeking accuracy, patients increasingly value a holistic approach and collaborative care model where medical professionals work together. There is a preference for discussing complex cases with a multi-disciplinary team comprising experts from relevant specialties rather than in isolation. Shared decision making that incorporates diverse perspectives is viewed as superior to relying on just one doctor's solitary assessment and recommendations. It allows for analyzing a condition from different angles and potentially overlooked dimensions, leading to more well-rounded care. Integrative medicine practiced through cooperation between healthcare providers, as against independent or fragmented treatment, provides comfort. Considering multiple valid viewpoints enable a collaborative synthesis of the best options tailored for an individual's specific needs. This evolving patient-centric preference for collectively deliberated therapeutic journeys over standalone consultations stimulates demand within the medical second opinion domain.

To learn more about this report, Request sample copy

One of the key challenges this emerging market faces is a lack of awareness among patients and physicians regarding the benefits of a second medical opinion. There needs to be more education around the role independent consultations can play in improving health outcomes and avoiding unnecessary or potentially risky medical procedures. Another challenge is a perception that second opinions undermine the authority of the primary treating physician. Establishing trust between all parties will take time as models evolve.

Market Opportunities – Growing Adoption of Telehealth:

The medical second opinion market presents significant growth opportunities. As health costs rise and treatment options grow more complex, consumers are increasingly seeking additional reassurance and peace of mind. Telehealth now makes independent consultations more convenient and affordable. There is demand from payers and employers to help reduce costs from expensive medical errors or unnecessary care. Standardizing credentials for virtual second opinion services could help address concerns around doctor qualifications.

Discover high revenue pocket segments and roadmap to it: Request sample copy

The condition segment includes cancer, neurological disorders, orthopedic disorders, organ transplant, ocular disorders, and others. Cancer accounts for the largest share in the medical second opinion market segment by condition and is anticipated to have 25.9% of the total share in 2024. This can be attributed to the rising risk factors associated with cancer across the globe. Fast paced and stressful lifestyles, harmful habits like smoking, lack of physical activity, and unhealthy diets have become common. All such risk factors contribute significantly to the rising incidence of various types of cancer. As cancer cases rise exponentially, more and more patients seek a second opinion to confirm diagnosis and explore the best treatment options. People are now more informed and proactive about getting irregular symptoms checked. Even if primarily diagnosed with cancer, many patients opt for a second opinion to eliminate any doubt regarding the disease extent and chosen therapy course.

Insights, By Service Provider: Advanced capabilities and wide acceptance propels hospital growth

The service provider segment includes physicians, hospitals, specialty clinics, health insurance companies, and others. Hospitals contribute the maximum share in terms of service providers for medical second opinions and are expected to hold 35.8% of the market share in 2024. This dominant position stems from various factors associated with advanced infrastructure and credentials of hospitals. Hospitals house highly skilled oncologists, surgeons, diagnosticians, and other specialists under one roof. Their faculties benefit from continuously sharing knowledge and collectively managing complex cases. This collaborative working environment enables delivering high quality and well-rounded second opinions. Hospitals are equipped with the latest diagnostic machines, specialized departments, and round the clock medical support staff. Comprehensive tests can be conveniently performed to analyze a case in-depth. Such exhaustive diagnostic facilities aid conclusive second consultations.

Regional Insights

To learn more about this report, Request sample copy

North America has established itself as the dominant region in the medical second opinion market over the past decade and is anticipated to hold 42.8% of the market share in 2024. The large and developed healthcare infrastructure in countries like the U.S. has enabled a wide acceptance of seeking additional medical opinions for complex cases. Several multi-specialty healthcare groups and hospitals in the region offer advanced second opinion services either bundled with insurance plans or available for direct payment. This has translated to high consumer awareness and a culture of considering alternative consultations for major illnesses or before undergoing invasive treatments. The presence of leading medical schools and research centers has also ensured that second opinions are provided by experts who can thoroughly review cases and advise on the latest standards of care.

The Asia Pacific region has emerged as the fastest growing market for medical second opinions globally. Rapid economic development across Southeast Asian countries like China and India has expanded access to healthcare and created a sizable population with medical insurance or ability to pay directly. At the same time, millions travel across borders each year for medical tourism in Asia Pacific, seeking affordable international treatments. This has encouraged the entry of new players providing remote consultations and second opinions to cater to international patients. Additionally, cultural factors play a role where family members are increasingly requesting additional consult workups particularly for elder parents.

Market Report Scope

Medical Second Opinion Industry News

• In October 2023, Pearl, the global leader in dental Artificial Intelligence solutions, announced that its Second Opinion chairside dental pathology detection assistance has been approved by the Turkish Medicines and Medical Devices Agency (TMMDA) as a Class IIa medical device. Turkey's authorization of Second Opinion adds to the solution's growing list of global regulatory clearances, which already includes the U.S., the U.K., and others.
• In July 2023, MDView, a U.S.-based end-to-end medical second opinion platform, launched its first service for patients looking for a second opinion on their medical imaging. After registering for a free MDView account, customers securely upload their medical imaging data and records, which are then matched with independent subspecialty radiologists who specialize in the submitted study.
• In March 2023, Cedars-Sinai, a hospital situated in the U.S., announced the launch of Cedars-Sinai Virtual Second Opinion, an online platform that connects people in need of difficult cardiac, spine, or gynecologic care with top-ranked experts who offer personalized treatment alternatives and virtual education.
• In March 2021, Accolade, a startup that assists individuals in understanding their health benefits, announced the acquisition of Innovation Specialists, LLC d/b/a 2nd.MD. Accolade will provide the most comprehensive healthcare navigation experience by merging the market leaders in benefit navigation, health advocacy, and expert medical opinion services, affecting over 400 customers and 9 million people.

*Definition: A medical second opinion is the process of seeking additional knowledge or advice from another healthcare professional or specialist about a patient's diagnosis, treatment plan, or medical condition. Patients typically seek this consultation when they want to confirm a diagnosis, explore alternative treatment options, gain more insight into their condition, or simply seek reassurance about their healthcare decisions.

Market Segmentation

• Condition Insights (Revenue, USD BN, 2019 - 2031)
  • Cancer
  • Neurological Disorders
  • Orthopedic Disorders
  • Organ Transplant
  • Ocular Disorders
  • Others
•  Service Providers Insights (Revenue, USD BN, 2019 - 2031)
  • Physicians
  • Hospitals
  • Specialty Clinics
  • Health Insurance Companies
  • Others
• Regional Insights (Revenue, USD BN, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • M | O | C Cancer Care & Research Centre
  • Yashoda Hospitals
  • Mayo Clinic
  • Cedars-Sinai Medical Center
  • Cleveland Clinic
  • Johns Hopkins Hospital
  • UCLA Medical Center
  • Cromwell Hospital
  • St Thomas' Hospital
  • The Wellington Hospital
  • Birmingham City Hospital
  • The University of Tokyo Hospital
  • St. Luke's International Hospital
  • Kameda Medical Center
  • Apollo Hospitals
  • Fortis Hospitals Group
  • Wockhardt Hospital
  • Medanta Hospital
  • Charité University Hospital Berlin
  • University Hospital Tuebing